A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers

Trial Identifier: D7550C00005
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03420092
Start Date: February 2018
Primary Completion Date: April 2018
Study Completion Date: April 2018
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations